Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NB0I
|
||||
| Former ID |
DNC014095
|
||||
| Drug Name |
2,4'-Dimethoxy-5,3'-dipropyl-biphenyl
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530176] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C20H26O2
|
||||
| Canonical SMILES |
CCCC1=CC(=C(C=C1)OC)C2=CC(=C(C=C2)OC)CCC
|
||||
| InChI |
1S/C20H26O2/c1-5-7-15-9-11-20(22-4)18(13-15)16-10-12-19(21-3)17(14-16)8-6-2/h9-14H,5-8H2,1-4H3
|
||||
| InChIKey |
GLDMMYBVNSMLGE-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [530176] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.